Latest Insider Transactions at Bausch Health Companies Inc. (BHC)
This section provides a real-time view of insider transactions for Bausch Health Companies Inc. (BHC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch Health Companies Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch Health Companies Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2022
|
Thomas Appio Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,389
-3.03%
|
$92,334
$6.59 P/Share
|
|
Jun 30
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,251
+1.79%
|
$18,008
$8.36 P/Share
|
|
Jun 30
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,560
+2.65%
|
$36,480
$8.36 P/Share
|
|
Jun 30
2022
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
822
+0.61%
|
$6,576
$8.36 P/Share
|
|
Jun 30
2022
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+3.49%
|
$29,304
$8.36 P/Share
|
|
Jun 30
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,663
+6.68%
|
$29,304
$8.36 P/Share
|
|
Jun 30
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,111
+1.13%
|
$32,888
$8.36 P/Share
|
|
Jun 24
2022
|
Richard Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+48.37%
|
-
|
|
Jun 24
2022
|
Argeris N Karabelas Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+21.75%
|
-
|
|
Jun 24
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+8.82%
|
-
|
|
Jun 24
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+42.0%
|
-
|
|
Jun 24
2022
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.45%
|
-
|
|
Jun 24
2022
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.63%
|
-
|
|
Jun 24
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+17.45%
|
-
|
|
Jun 24
2022
|
Robert N Power Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+20.2%
|
-
|
|
Jun 24
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+22.13%
|
-
|
|
Jun 24
2022
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+26.05%
|
-
|
|
Jun 24
2022
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
34,387
+22.65%
|
-
|
|
Jun 20
2022
|
John S Barresi SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
16,898
+50.0%
|
-
|
|
May 13
2022
|
Richard Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,317
+50.0%
|
-
|
|
May 10
2022
|
Thomas Appio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,022
+3.1%
|
-
|
|
May 10
2022
|
Robert Spurr President, U.S. Businesses |
BUY
Exercise of conversion of derivative security
|
Direct |
22,235
+9.39%
|
-
|
|
May 10
2022
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
33,714
-2.31%
|
$303,426
$9.4 P/Share
|
|
May 10
2022
|
Joseph C Papa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
366,130
+8.24%
|
-
|
|
May 10
2022
|
Seana Carson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,467
+4.78%
|
-
|
|
May 03
2022
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
747
-3.22%
|
$13,446
$18.66 P/Share
|
|
Apr 14
2022
|
Robert Spurr President, U.S. Businesses |
SELL
Open market or private sale
|
Direct |
1,595
-1.73%
|
$35,090
$22.19 P/Share
|
|
Mar 31
2022
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,340
+1.52%
|
$29,480
$22.85 P/Share
|
|
Mar 31
2022
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,504
+0.47%
|
$33,088
$22.85 P/Share
|
|
Mar 31
2022
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,340
+9.28%
|
$29,480
$22.85 P/Share
|
|
Mar 31
2022
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,340
+2.08%
|
$29,480
$22.85 P/Share
|
|
Mar 31
2022
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,668
+1.28%
|
$36,696
$22.85 P/Share
|
|
Mar 31
2022
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+0.3%
|
$6,600
$22.85 P/Share
|
|
Mar 15
2022
|
Robert Spurr President, U.S. Businesses |
SELL
Open market or private sale
|
Direct |
4,846
-5.0%
|
$106,612
$22.2 P/Share
|
|
Mar 10
2022
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-0.51%
|
$18,458
$22.56 P/Share
|
|
Mar 08
2022
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Open market or private sale
|
Direct |
3,889
-4.01%
|
$81,669
$21.76 P/Share
|
|
Mar 03
2022
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,564
-1.16%
|
$127,972
$23.61 P/Share
|
|
Mar 03
2022
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
4,074
-4.03%
|
$93,702
$23.61 P/Share
|
|
Mar 03
2022
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,643
-1.14%
|
$290,789
$23.61 P/Share
|
|
Mar 03
2022
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,242
-1.03%
|
$28,566
$23.61 P/Share
|
|
Mar 03
2022
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
6,926
-4.07%
|
$159,298
$23.61 P/Share
|
|
Mar 03
2022
|
Frederick Munsch SVP, Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
608
-2.56%
|
$13,984
$23.61 P/Share
|
|
Mar 03
2022
|
Robert Spurr President, U.S. Businesses |
SELL
Payment of exercise price or tax liability
|
Direct |
4,074
-4.03%
|
$93,702
$23.61 P/Share
|
|
Mar 02
2022
|
Robert Spurr President, U.S. Businesses |
BUY
Grant, award, or other acquisition
|
Direct |
35,627
+26.07%
|
$855,048
$24.17 P/Share
|
|
Mar 02
2022
|
Robert Spurr President, U.S. Businesses |
SELL
Open market or private sale
|
Direct |
1,595
-2.38%
|
$36,685
$23.37 P/Share
|
|
Mar 02
2022
|
Thomas Appio Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
152,690
+24.1%
|
-
|
|
Mar 02
2022
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Open market or private sale
|
Direct |
11,077
-9.87%
|
$254,771
$23.37 P/Share
|
|
Mar 01
2022
|
Joseph F Gordon Pres&Co-Head Bausch&Lomb/Int'l |
SELL
Open market or private sale
|
Direct |
6,338
-5.35%
|
$145,774
$23.82 P/Share
|
|
Feb 28
2022
|
Joseph C Papa Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,115
-0.46%
|
$122,760
$24.06 P/Share
|
|
Feb 27
2022
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,020
-1.61%
|
$96,480
$24.35 P/Share
|